Matches in Wikidata for { <http://www.wikidata.org/entity/Q90645845> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- Q90645845 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q90645845 description "scientific article published on 01 December 2018" @default.
- Q90645845 description "wetenschappelijk artikel" @default.
- Q90645845 description "наукова стаття, опублікована в грудні 2018" @default.
- Q90645845 name "Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models" @default.
- Q90645845 name "Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models" @default.
- Q90645845 type Item @default.
- Q90645845 label "Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models" @default.
- Q90645845 label "Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models" @default.
- Q90645845 prefLabel "Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models" @default.
- Q90645845 prefLabel "Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models" @default.
- Q90645845 P1433 Q90645845-6A1DC416-9D99-4096-A291-81E5BF3836BB @default.
- Q90645845 P1476 Q90645845-08A6FB9D-84F9-4A80-8F81-68EB988A5E1A @default.
- Q90645845 P2093 Q90645845-259CC484-ECE2-4AE2-A62B-36EA3D9043C2 @default.
- Q90645845 P2093 Q90645845-30C118E3-5E17-4EFB-82A0-29A716408456 @default.
- Q90645845 P2093 Q90645845-4A8DE151-E428-4D9B-B2F8-6CE7BBF505B5 @default.
- Q90645845 P2093 Q90645845-5682C298-2150-411F-B3F4-64EDA45A4AD1 @default.
- Q90645845 P2093 Q90645845-8A624806-DD4B-485A-AE80-A0366B6FD9AB @default.
- Q90645845 P2093 Q90645845-9B5BECB8-F69C-43A3-95B3-1CD116BDD561 @default.
- Q90645845 P2093 Q90645845-A81C4ADA-EC1B-4516-A2CE-92B53752DEC0 @default.
- Q90645845 P2093 Q90645845-E2EE265F-1417-48D6-BAB5-47879C0FA3E6 @default.
- Q90645845 P2093 Q90645845-F1D662B1-775F-4103-A75D-BC1B7467B59D @default.
- Q90645845 P2860 Q90645845-0BACFF01-BCE5-49F1-AEC7-7DB085755FDA @default.
- Q90645845 P31 Q90645845-0489FC74-B70B-43D7-9461-A45A47A287F2 @default.
- Q90645845 P356 Q90645845-339ABB2A-6214-4669-A1B2-7C737AA62841 @default.
- Q90645845 P433 Q90645845-FF1AE9BD-4FEC-4244-8BBE-CA2CA8762420 @default.
- Q90645845 P478 Q90645845-61F85F22-6F45-4B88-9CBD-71E9C7C233F4 @default.
- Q90645845 P50 Q90645845-42CEF01C-2079-457B-9CA5-D45B43C6B3CC @default.
- Q90645845 P50 Q90645845-4F038E8B-26BF-4115-99BF-10B12CE3794A @default.
- Q90645845 P50 Q90645845-50264655-A632-4CE3-B9D8-3BBB7822B769 @default.
- Q90645845 P50 Q90645845-55548650-444C-4765-AC4A-9A222FE7240E @default.
- Q90645845 P50 Q90645845-649E0C36-F7BA-45A0-90F7-4F5CD276925C @default.
- Q90645845 P50 Q90645845-73F583C3-79DF-4163-B9AF-8AC75A874CA1 @default.
- Q90645845 P50 Q90645845-7F7C4514-AD1F-485A-AED8-9A087D4077E6 @default.
- Q90645845 P50 Q90645845-9534BD45-6A1D-4918-A02F-80C94842484A @default.
- Q90645845 P50 Q90645845-9AE6FF1E-7C73-4455-BCA0-FD54B697866B @default.
- Q90645845 P50 Q90645845-B295F973-84D4-402C-B5DA-B1010AA8D73C @default.
- Q90645845 P50 Q90645845-BC78A0CC-266C-49D5-B4FF-C6D45A95075D @default.
- Q90645845 P50 Q90645845-C3D2C8E0-EABC-4968-9B0F-A7A3A40EC01F @default.
- Q90645845 P50 Q90645845-C6C52C2C-F072-48FD-9C33-B77D55021316 @default.
- Q90645845 P50 Q90645845-E0CA822A-B67C-4D84-821A-F7D473A08A61 @default.
- Q90645845 P50 Q90645845-E62DDF55-B4F9-4AB5-A7FB-A1E49CFAC580 @default.
- Q90645845 P50 Q90645845-EE7AF5ED-90E7-4305-B97D-84C1F5628875 @default.
- Q90645845 P50 Q90645845-F494B4CF-88F7-4A9A-8E4A-CB905F74309F @default.
- Q90645845 P577 Q90645845-5A6EE3E8-B9E3-4B09-9370-943BBFCB71DD @default.
- Q90645845 P698 Q90645845-EDB1CEC3-9DD5-48CE-A10C-C8607C4FB364 @default.
- Q90645845 P356 SCITRANSLMED.AAT3392 @default.
- Q90645845 P698 30567927 @default.
- Q90645845 P1433 Q1573955 @default.
- Q90645845 P1476 "Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models" @default.
- Q90645845 P2093 "Darren Bates" @default.
- Q90645845 P2093 "Ian N Foltz" @default.
- Q90645845 P2093 "Joanne Lin" @default.
- Q90645845 P2093 "Larissa Atangan" @default.
- Q90645845 P2093 "Liying Deng" @default.
- Q90645845 P2093 "Qing Chen" @default.
- Q90645845 P2093 "Tina Meng" @default.
- Q90645845 P2093 "Todd Hager" @default.
- Q90645845 P2093 "Zhulun Wang" @default.
- Q90645845 P2860 Q27860930 @default.
- Q90645845 P31 Q13442814 @default.
- Q90645845 P356 "10.1126/SCITRANSLMED.AAT3392" @default.
- Q90645845 P433 "472" @default.
- Q90645845 P478 "10" @default.
- Q90645845 P50 Q57320820 @default.
- Q90645845 P50 Q61456695 @default.
- Q90645845 P50 Q89676045 @default.
- Q90645845 P50 Q89676047 @default.
- Q90645845 P50 Q89676049 @default.
- Q90645845 P50 Q89676061 @default.
- Q90645845 P50 Q90645803 @default.
- Q90645845 P50 Q90645805 @default.
- Q90645845 P50 Q90645810 @default.
- Q90645845 P50 Q90645814 @default.
- Q90645845 P50 Q90645818 @default.
- Q90645845 P50 Q90645822 @default.
- Q90645845 P50 Q90645825 @default.
- Q90645845 P50 Q90645829 @default.
- Q90645845 P50 Q90645832 @default.
- Q90645845 P50 Q90645836 @default.
- Q90645845 P50 Q90645840 @default.
- Q90645845 P577 "2018-12-01T00:00:00Z" @default.
- Q90645845 P698 "30567927" @default.